1. Home
  2. TH vs ANAB Comparison

TH vs ANAB Comparison

Compare TH & ANAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Target Hospitality Corp.

TH

Target Hospitality Corp.

HOLD

Current Price

$13.72

Market Cap

1.4B

ML Signal

HOLD

ANAB

AnaptysBio Inc.

HOLD

Current Price

$62.19

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TH
ANAB
Founded
1978
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.3B
IPO Year
2017
2015

Fundamental Metrics

Financial Performance
Metric
TH
ANAB
Price
$13.72
$62.19
Analyst Decision
Strong Buy
Buy
Analyst Count
2
11
Target Price
$13.00
$74.64
AVG Volume (30 Days)
968.5K
601.6K
Earning Date
05-18-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
91.02
EPS
N/A
N/A
Revenue
$320,635,000.00
$234,603,000.00
Revenue This Year
$12.19
N/A
Revenue Next Year
$35.63
$31.11
P/E Ratio
N/A
N/A
Revenue Growth
N/A
157.01
52 Week Low
$5.97
$15.40
52 Week High
$14.13
$68.39

Technical Indicators

Market Signals
Indicator
TH
ANAB
Relative Strength Index (RSI) 83.11 55.41
Support Level $7.95 $43.67
Resistance Level N/A $67.69
Average True Range (ATR) 0.58 4.07
MACD 0.46 -0.57
Stochastic Oscillator 94.35 60.16

Price Performance

Historical Comparison
TH
ANAB

About TH Target Hospitality Corp.

Target Hospitality Corp is a vertically integrated specialty rental and hospitality services company in the United States. The company provides vertically integrated specialty rental and comprehensive hospitality services, including catering food services, maintenance, housekeeping, grounds-keeping, on-site security, overall workforce lodge management, and laundry service. The company has three reportable segments: HFS - South, which provides specialty rental and hospitality services to the natural resources and development industry; WHS, which provides construction and hospitality solutions for critical mineral and data center projects; and Government, which provides specialty rental and hospitality services under government contracts.

About ANAB AnaptysBio Inc.

AnaptysBio Inc is a clinical-stage biotechnology company. The company is focused on developing antibody product candidates for unmet medical needs in inflammation and immuno-oncology. The company is developing immune cell modulating antibodies, including two wholly owned checkpoint agonists in clinical-stage development, for autoimmune and inflammatory diseases; rosnilimab, PD-1 agonist in a Phase 2b trial for the treatment of moderate-to-severe rheumatoid arthritis (RA) and a Phase 2 trial for the treatment of moderate-to-severe ulcerative colitis (UC); and ANB032, BTLA agonist, in a Phase 2b trial for the treatment of moderate-to-severe atopic dermatitis (AD).

Share on Social Networks: